Roche to buy InterMune for $8.3 billion

  • by: Michelle Fay Cortez , Bloomberg News
  • Updated: August 25, 2014 - 9:58 PM

Cancer drug giant is buying shares in company awaiting U.S. approval of a drug for rare disease.

ADVERTISEMENT

Connect with twitterConnect with facebookConnect with Google+Connect with PinterestConnect with PinterestConnect with RssfeedConnect with email newsletters

ADVERTISEMENT

Advertisement
Golden Gavel by Star Tribune

Countdown to great deals

Bid Sept. 21-29

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT